Canadian Journal of Infectious Diseases and Medical Microbiology (Jan 2007)

Treatment of Candiduria with Micafungin: A Case Series

  • Danny Lagrotteria,
  • Coleman Rotstein,
  • Christine H Lee

DOI
https://doi.org/10.1155/2007/768734
Journal volume & issue
Vol. 18, no. 2
pp. 149 – 150

Abstract

Read online

There has been a gradual increase in the incidence of non-Candida albicans-related nosocomial infections. Candida glabrata urinary tract infections have increased in frequency, and treating these infections can be difficult because the organism may be resistant to fluconazole. A newer antifungal agent, micafungin, which belongs in the class of echinocandins, provides an alternative and effective therapy against C glabrata. The present report describes three cases of C glabrata-associated urinary tract infections successfully treated with micafungin. To the authors’ knowledge, this is the first report of successful treatment of C glabrata and azole-resistant C albicans-associated urinary tract infection with an echinocandin.